SEC Form 4 · accession 0001144204-18-012644
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric R. Mortensen
Officer — Chief Medical Officer
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2018 | A | 14,000 | $0.00 | A | 16,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares represent restricted stock units which shall vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting.
- F2Includes 2,500 shares of common stock owned by the reporting person and 14,000 restricted stock units granted on February 28, 2018 and reported on this Form 4.